BOLT WILLIAM J 4
4 · ABIOMED INC · Filed May 16, 2018
Insider Transaction Report
Form 4
ABIOMED INCABMD
BOLT WILLIAM J
SVP, QA and Regulatory Affairs
Transactions
- Tax Payment
Common Stock, $.01 par
2018-05-13$372.68/sh−1,930$719,272→ 55,694 total - Tax Payment
Common Stock, $.01 par
2018-05-15$375.67/sh−1,484$557,494→ 62,210 total - Award
Common Stock, $.01 par
2018-05-15+8,000→ 63,694 total
Holdings
- 3,334
Stock Option (Right to Buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying) - 2,000
Stock Option (Right to Buy)
Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying) - 3,000
Stock Option (Right to Buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying)
Footnotes (5)
- [F1]Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F2]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F4]Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- [F5]Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 15, 2017. One third of these restricted stock units vested on May 15, 2018 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone and upon the first anniversary of the date of the grant with the remaining vesting on the second and third anniversaries of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates.